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What Can Be Learned from Studying
Asian Health Problems?
by Philip S. Chen, Jr.*
The National Institutes of Health, owing to its
broad mandate to pursue and support acquisition of
knowledge in biomedicine, is very much concerned
with any investigations leading to better under-
standing of the causes and control of human dis-
eases. One approach is to study health and illness in
special subsets ofthe United States population and
of populations in foreign countries.
In this paper, I shall touch briefly on a number of
health problems and disease-oriented research top-
ics looked at from the special perspective of Asian
and Asian-American populations, hopefully to sen-
sitize perceptions about the contributions that such
studies can make to our total understanding ofhow
best to achieve health and conquer disease.
The new goal of the World Health Organization
(WHO) is "Health for all by the year 2000." "The
aim is to enable all people ofthe world to attain an
acceptable level ofhealth and to lead a socially and
economically productive life." (1).
Population
Asia, withjust over 20% ofthe world's land area,
has over 55% of the world's population. The two
most populous countries, China and India, alone
account for over 40% ofthe world's population, and
Indonesiais the fifth mostpopulous nation, Japan is
seventh, followed by Bangladesh and Pakistan.
An important factor in determining the health of
a nation's population is the level of economic
development, which in turn is related to the rate of
population growth. Growth in population puts enor-
mous pressures on many aspects of a nation's
economy. The larger the number of infants and
young children who need to be fed and cared for,
the greater the number of those who will live in
poverty, be uneducated, and underfed.
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The annual rates of population growth range
from 0.4% in northern Europe to 1.0% in North
America and the U.S.S.R. to 1.2% in Japan and
1.6% in China, to2.6% in South Asia, and to 3.3% in
Middle America. The world average is 1.9%.
Control ofpopulation growth rates will correlate
with improvements in health, and a number of
Asian countries are continuing to struggle with this
significant aspect affecting their national futures.
Malnutrition
Recent estimates by the Food and Agriculture
Organization (FAO) ofthe United Nations suggest
that about 450 million people do not receive enough
food. Thedistributionofmalnutritionisveryuneven
around the world, even within aregion such as Asia
(1). In high-income countries with low rates of
population growth, the general problem is obesity
due to overeating (i.e., malnutrition of affluence).
These countries include Japan and Oceania, as well
as those in North America and Europe. In middle-
income developing countries, some of which are in
Asia, there are high rates of population growth,
poor income and land distribution, resulting in food
deprivation for many. The higher income portion of
the population may also suffer from malnutrition of
affluence. The poorest countries, including those in
Asia and the middle of Africa, are those in which
hunger and malnutrition are most severe. An
estimated one-third to one-halfoftheir inhabitants
are victims of malnutrition.
China and other Asian countries with planned
economies are in a special category. Although per
capita GNP is in the lower range, most observers
report that overt malnutrition is not common. Thus
it is possible for a nation to improve the nutritional
status ofits populace by devoting long-range atten-
tion to this issue. Health research per se is not
particularly competent to contribute to the solu-
tions ofthese kinds of malnutrition problems.
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In Asia, as is true even ofamodern industrialized
nation such as the United States, there are consid-
erable variations in the quality of health care
available to the general population. One general
indicatorthathas beenused isthe ratioofphysicians
to the number ofinhabitants. In the United States
this ratio is about 168 per 100,000 population, which
is roughly double the physician:population ratio
worldwide of80.8 per 100,000. In Asia, the number
per 100,000 population ranges from a surprising
high of208 in Mongolia, to 26 and 27in Pakistan and
India. The comparable figures for Japan and China
are 118.3 and 38.4, respectively, based on the latest
World Health Organization figures for 1980. At the
low end are Thailand with 12.1 and Indonesia with
only 7 (2).
These figures may be misleading, in the sense
that not all health care is delivered by physicians.
For example, we have all heard of the great
contributions of the "barefoot doctors" in the Peo-
ple's Republic ofChina. These paraprofessionals, as
well as the more highly educated physicians, are
trained in the use oftraditional Chinese medicine as
well as in Western medical knowledge. Much pub-
licity had been given to the use of acupuncture
following former President Nixon's trip to China,
and his personal physician, Dr. Walter R. Tkach,
encouraged the NIH to support research on acu-
puncture. At that time, I was working for the
National Institute ofGeneral Medical Sciences, and
Dr. DeWitt Stetten, the then Director of NIGMS,
was asked by the NIH Director, Dr. Robert Q.
Marston, to initiate an acupuncture research pro-
gram. The NIGMS convened international work-
shops, and a review committee was established
within the Division of Research Grants to evaluate
grant applications in acupuncture. An initial flurry
of research began, coincident with the opening of
many acupuncture clinics scattered around this
country. In the last half dozen years or so, howev-
er, interest in acupuncture has diminished and
stabilized. It is generally accepted that acupunc-
ture can exert an analgesic effect, mediated per-
haps through some mechanism involving the endor-
phins. The claims for therapeutic effects of acu-
puncture in the cure of a wide variety of diseases
are generally not supported by reliable research
evidence.
An example of the contribution of traditional
Chinese medicine to Western medical knowledge is
the discovery of ephedrine through scientific stud-
ies of an old Chinese herbal concoction. Several
decades ago, the Chinese-American pharmacolo-
gist, Dr. K. K. Chen, performed, in this country,
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the work which led to the acceptance of ephedrine
as a standard pharmaceutical agent.
I might add at this point a brief comment about
the reported remarkable improvement in health
care in the People's Republic of China, and the
manner in which it was attained. Certain lessons
can be learned from this which have applicability to
other Asian countries as well as to the United
States.
Soon after founding of the People's Republic of
China, Chairman Mao issued four cardinal princi-
ples as guidelines for medical and health work in
China. One was to stress prevention, another was
to unite the practitioners of Chinese traditional
medicine and of Western medicine. Today it is
accepted that China has advanced considerably: in
its health delivery system, using barefoot doctors,
health aides, and midwives; in its medical education
system; in its production ofpharmaceuticals, medi-
cal instruments and apparatus; in its sanitation
efforts, resulting in eradication or control of small-
pox, cholera, plague, and venereal diseases; in its
family planning programs; and in its integration of
traditionalmedicinewithmodernWesternpractices.
Cancer
In a monumental study recently completed in the
People's Republic of China, data on cancer mortal-
ity over the three-year interval 1973-1975 were
collected among a population of840 million Chinese
using a cadre of approximately 600,000 health
workers. Results were issued in a Chinese publica-
tion entitled Atlas of Cancer Mortality for the
People's Republic ofChina (3). The data are most
dramatically displayed in colored maps showing
mortality rates for various cancers by county.
About 700,000 deaths per year were due to cancer.
Some dramatic differences between the Chinese
and the U.S. data can be highlighted. In the United
States, the leading cause ofcancermortality is lung
cancer in men and breast cancer in women. In
contrast, the leading cause of cancer mortality in
both men and women in China is stomach cancer,
followed by cancers of esophagus and liver. In the
United States lung and breast cancer are followed
by colon and rectal cancer.
Overall cancer mortality in China is higher in
urban areas, in males, and in certain ethnic minori-
ties. Among children under 15 years ofage, cancer
is the cause of only 0.8 percent of deaths. The
overall statistics placed China lower in cancer
mortalitythanmostindustrializednationsbuthigher
than many other nations in Africa, Asia, and Latin
America.
Environmental Health PerspectivesCertain variations within the country are very
interesting from a research standpoint. For exam-
ple, esophogeal cancer varies markedly with geo-
graphical areas and there are six areas in China
with unusually high rates. For example, in Linxian,
Hanan province, esophogeal cancer rates may be
the highest in the world, with one death in six in
this county attributed to esophageal cancer.
The county maps of China show that there are
high rates ofnasopharyngeal carcinoma in southern
China. Several factors are associated with this
cancer. For example, antibodies against Epstein-
Barr virus tend to be elevated in patients with this
disease and can be used as an assay in screening
programs. Genetic factors may also play a role,
because there are higher rates among Cantonese
who migrated to that region several generations
ago. Also there are high incidences of liver cancer
on the southeastern coastal provinces and in an
area of northeastern China, which may be linked
with liver disease caused by viral hepatitis B, with
ingestion as a contaminant in the diet of aflatoxin,
known as a potent liver carcinogen, and with
possible exposure to hepatotoxic pesticides.
Cancers of the lung and bladder are found to be
more common in major urban areas, such as Shang-
hai, Tiensin and Beijing. Contributingfactors might
be an increased level of cigarette smoking or of
industrial pollutants and the use of coal-burning
stoves in unventilated homes. Dr. Robert Miller of
the National Cancer Institute reported on a valu-
able data resource in Shanghai-a tumor registry
containing information on incidence and mortality
going back to the 1960s (4). By comparing cancer
incidence in Shanghai with that for Chinese-
Americans and other ethnic groups in the United
States, epidemiologists may be able to gain useful
knowledge concerning possible etiologic factors.
The Shanghai data show that cancer ofthe prostate
and Ewing's sarcoma of bone are rare, whereas
stomach cancer is the most frequent neoplasia.
The National Cancer Institute has sponsored a
number ofexchange visits ofscientists between our
country and China. Several NCI epidemiologists
have spent time traveling in or working in China.
Reports on the special clustering of cancer in
domestic animals, such as pigs, chickens, and
ducks, have provided very useful clues in research
on the etiology of human cancer.
Dr. Robert Miller has also worked in Japan and
related the interesting discovery of a very high
incidence of primary respiratory tract cancers in
Japanese who worked in a mustard gas factory
duringWorld War II. The latest statistics indicated
that 73 of 500 workers had fallen victim to such
cancers.
April 1982
Genetic Diseases
A recent visitor to Beijing reported to the WHO
on quantitative differences between the Chinese
population and the general U.S. population with
respect to several genetic diseases. For example,
cystic fibrosis and several leukodystrophies were
seen relatively infrequently among the Chinese.
However, other genetic diseases are observed
relatively frequently, such as Down's syndrome
and other chromosomal defects, Huntington's cho-
rea, phenylketonuria, homocystinuria, Duchenne's
muscular dystrophy, and even Tay-Sachs disease in
a certain province (Hanan). The Tay-Sachs gene
may have been introduced into the latter geo-
graphic area during the 13th century, when it was
said thatJewish traders had lived in Kai-feng City,
marrying Chinese spouses.
The unavailability of special diets such as low-
phenylalanine for patients with phenylketonuria is
a problem. U.S. medical scientists, through visits
to China, are helpingto provide advice with respect
to better diagnostic methods and treatment modal-
ities for genetic diseases. As the general level of
technology improves in the study of genetic dis-
eases, there willundoubtedlybe significant findings
that will become evident owing to the very large
and yetmostly homogeneous population in acountry
as large as China. The same can be said of other
Asian countries.
Infectious Diseases
Most Asian populations do not differ from those
in Western countries in their basic reactions to
disease agents. However, a number of infectious
diseases remain very serious problems in particular
Asian populations, in contrast to the U.S. where
they are rarely or never seen.
Parasitic Diseases
Malaria continues to be of global impact, espe-
cially in South Asia. In 1976 there were over 8
million cases. One ofthe serious problems today is
falciparummalaria, resistant tochemotherapy. Con-
siderable research efforts are aimed atimmunologic
approaches, i.e., the development of a vaccine.
There is evidence that vaccines might be able to be
produced from practically all stages ofthe parasite
in man (sporozoites, schizonts, gametocytes, mero-
zoites). One intriguing approach is to attempt to
interrupt transmission, in effect by "vaccinating"
the mosquito.
Transmitted by snails as a vector, Schistosomia-
sis has increased in incidence as a result of large-
131scale water impoundments and artificial man-made
lakes. Some200millionpeople are infected. Research
is aimed atimproved chemotherapeutic agents. The
most recent drug is called Praziquantel, said to be
especially useful in treating S. hematobium.
Acute Diarrheal Diseases
Diarrheal diseases are major killers of children,
causing in excess of 5 million deaths annually.
Rotavirus and enterotoxic E. coli as well as cholera
are the major culprits.
Tuberculosis
Tuberculosis, once a public health problem in
Western nations, accounts for 4th place among
causes of death in Southeast Asia. There are 3.5
million new cases annually with 0.5 million deaths.
Leprosy
Fourmillion individuals are infected with leprosy
in Southeast Asia, mostly in India.
Infectious Disease Research
Research on these "tropical" and other diseases
has been assisted by planned efforts in which NIH
hasplayedasignificantrole. TheUnitedStates-Japan
Cooperative Science Program is now in its 16th
year. This program is coordinated for the U.S. side
by the National Institute ofAllergy and Infectious
Diseases (5).
Certainlaboratorieslocated inAsiahavereceived
considerable encouragement and sponsorship by
Western nations. The International CenterforDiar-
rheal Diseases Research (ICDDR) in Dacca, Bangla-
desh, and also the International Center for Medical
Research in Ching-Mai, Thailand, are sites where
NIH staffhave activelyparticipated inmanyresearch
studies. The NationalInstitute ofAllergyand Infec-
tious Diseases is currently conducting field trials of
hepatitis B vaccine for both its primary effect in
protecting a mother from hepatitis as well as a
possible secondary effect to protect offspring from
later developing liver cancer. This is obviously a
very long-term clinical trial but one with enormous
implications, both for infectious disease and in can-
cer prevention.
Radiation Exposure
One truly unique opportunity available only in
Asia is the ability to study the long-term effects of
radiation exposure in the atomic bomb survivors of
Hiroshima and Nagasaki, Japan. Nowhere else in
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the world is there such a population. A number of
NIH staff, primarily from the NCI, but also from
NIEHS and other institutes, have worked at the
Radiation Effects Research Foundation (RERF)
and its predecessor the Atomic Bomb Casualty
Commission (ABCC).
The evidence that whole body irradiation can
produce leukemia was firmly established by obser-
vations of the occurrence of acute and of chronic
leukemia, both of which began to increase several
years after the atomic bombs were dropped, peak-
ing some 6 years later, but with continued higher
incidence longafterwards. Priorto such direct obser-
vations on a large exposed population, the evidence
for radiation-induced leukemia was based on indi-
vidual case reports ofearly radiation workers or of
radiologists, and experimental studies ofthe effects
of x-rays in mice.
Despite the fact that their populations greatly
exceed ours, the Asian countries have many ofthe
same problems. Their leading causes of death are
the same as ours: heart disease, malignant neo-
plasms and accidents. They are beset by the same
behavioral factors as we are. Smoking is well rec-
ognized as a leading environmental health hazard.
Just consider a few statistics on the number of
cigarettes consumed by persons aged 15 or older in
1973: In the U.S. it was 3850; inJapan, 3240; in the
U.K., 3230; in Hong Kong, 2780; in Singapore,
2490; in Pakistan, 760; and in India, 170. Clearly,
several Asian countries are approachingthe U.S. in
ahighcigaretteconsumption, anditcanbeexpected
that lung cancer, emphysema, heart disease, etc.
will increase as a result. Indeed China, India, Indo-
nesia, and the Republic of Korea are among the
world's top 10 tobacco-producing countries.
In closing, the participation by Asian scientists in
thetotalbiomedical research effort should benoted.
Many researchers and research support staffat the
NIH as well as around the country are from an
Asian heritage. Currently, the largest number of
participants inthe NIH Visiting Program (compris-
ingVisitingFellows, VisitingAssociates, and Visting
Scientists) comes from Japan. Many other Asian
countries are represented as well. Since the com-
mencement of diplomatic relations with the Peo-
ple'sRepublicofChina, anincreasingflowofresearch
trainees, primarily Visiting Fellows, have come
from the PRC. The "cultural revolution" unfortu-
natelyhadcausedamassivedisruptionintheresearch
and educational system in China; as a consequence,
its biomedical researchers were not able to keep
pacewiththerapidprogressinscience. TheNational
Institutes of Health is contributing to the upgrad-
ing ofbiomedical research capability in that nation
by providing many training opportunities for PRC
Environmental Health Perspectivesscientists within the intramural NIH laboratories
and clinics.
Health research and efforts to improve health
care are peaceful activities which can greatly con-
tribute to humanwell-being. Theyare noble endeav-
ors ofwhich mankind can be proud. Such studies of
and by Asians and Asian-Americans help to meet
our own aspirations for health as well as the overall
global goal set by the World Health Organization.
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